SF
CVS icon

Symphony Financial’s CVS Health CVS Stock Holding History

Symphony Financial’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,275
Closed -$261K – 214
2024
Q1 		$261K Sell
3,275
-554
-14% -$42.3K 0.06% 156
2023
Q4 		$296K Sell
3,829
-135
-3% -$9.61K 0.06% 166
2023
Q3 		$276K Sell
3,964
-1,802
-31% -$128K 0.07% 136
2023
Q2 		$396K Sell
5,766
-1,801
-24% -$128K 0.1% 136
2023
Q1 		$565K Sell
7,567
-220
-3% -$18.4K 0.15% 118
2022
Q4 		$716K Buy
7,787
+489
+7% +$47.2K 0.19% 105
2022
Q3 		$708K Buy
7,298
+759
+12% +$75.1K 0.23% 96
2022
Q2 		$610K Sell
6,539
-1,432
-18% -$140K 0.18% 113
2022
Q1 		$826K Sell
7,971
-26
-0.3% -$2.73K 0.19% 97
2021
Q4 		$833K Buy
7,997
+1,216
+18% +$112K 0.23% 80
2021
Q3 		$589K Sell
6,781
-767
-10% -$64.2K 0.21% 86
2021
Q2 		$628K Buy
7,548
+58
+0.8% +$4.75K 0.21% 81
2021
Q1 		$559K Buy
7,490
+2,847
+61% +$207K 0.15% 102
2020
Q4 		$325K Buy
4,643
+607
+15% +$39.5K 0.12% 122
2020
Q3 		$236K Buy
4,036
+705
+21% +$43.9K 0.1% 122
2020
Q2 		$216K Buy
+3,331
New +$210K 0.1% 128

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Symphony Financial's CVS Position: Q2 2024 in Review

Symphony Financial sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,275 shares — an estimated $261K sold.

Symphony Financial first reported a position in CVS in Q2 2020 and held it in 16 quarters. The position peaked at $833K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Symphony Financial reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Symphony Financial sold 3,275 CVS Health shares in Q2 2024, an estimated $261K.
  • Symphony Financial first reported a position in CVS Health in Q2 2020 and held it in 16 quarters.
  • Symphony Financial's CVS Health position peaked at $833K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Symphony Financial's 13F filing for Q2 2024, filed 18 Jul 2024.